Commentary Australian chief medical officers have embarked on a campaign to rehabilitate the AstraZeneca vaccine as a suitable COVID-19 jab. The vaccine lost much of its reputational shine when it was disclosed in the media that there had been several deaths from blood clotting issues after vaccinations. The blood clotting issue involves thrombosis with thrombocytopenia…
Reviving AstraZeneca’s Stocks Is a Matter of Confidence
Majority of Hospitalized COVID-19 Patients are Fully Vaccinated at Israel Hospital: Doctor
An Israeli doctor says that the majority of COVID-19 patients hospitalized at his hospital are fully vaccinated and those with severe illness have also been vaccinated. Talking with Channel 13 TV News on August 5, Dr. Kobi Haviv, medical director of Herzog Hospital in Jerusalem said that “85 to 90 percent of the hospitalizations are…
Majority of Hospitalized COVID-19 Patients at Hospital in Israel Are Fully Vaccinated: Doctor
An Israeli doctor says that the majority of COVID-19 patients hospitalized at his hospital are fully vaccinated and those with severe illness have also been vaccinated. Talking with Channel 13 TV News on August 5, Dr. Kobi Haviv, medical director of Herzog Hospital in Jerusalem said that “85 to 90 percent of the hospitalizations are…
Israel Announces Booster Pfizer Shots for Those Over 60
The Israeli government announced it will offer a third shot of the Pfizer/BioNTech COVID-19 vaccine to citizens over 60 years old, amid ongoing efforts to slow the spread of the more contagious Delta variant of the CCP virus. Naftali Bennett, the Israeli prime minister, announced in a statement on Friday that President Isaac Herzog and his wife Michal were among the…
2 Doses of Pfizer or Astrazeneca Vaccine Effective Against Delta COVID-19 Variant: Study
The Pfizer or AstraZeneca vaccines for COVID-19 are nearly as effective against the Delta variant as they are against the previously dominant Alpha variant, when the person receives two doses of the vaccine, a new study published on Wednesday suggests. The highly contagious Delta variant, first identified in India in late 2020, is now the…
Making Sense of the Slow Vaccine Uptake
Commentary In an illuminating op-ed published in The Epoch Times, Tshung Chang purports to explain why the COVID-19 vaccination program in Australia is proceeding slowly. Only 1.94 million out of 25 million Australians are fully vaccinated, which is 7.7 percent of the population. This places Australia near the bottom of OECD countries that have embarked…
Pfizer Shots Could Be Available to Australians Under-40 in September
Pfizer vaccines could be available to Australians under 40 as early as September or October, the head of the COVID-19 vaccine task force said on Tuesday. Lieutenant-General John Frewen told reporters that currently, there was a limited amount of imported Pfizer vaccines and an abundance of locally-made AstraZeneca. Therefore the current age group priorities would…
Pfizer Jab Effectivity Against COVID-19 Infection Drops to 64 Percent: Israeli Health Ministry
The ability of the Pfizer/BioNTech mRNA vaccine to prevent infections and prevent symptomatic COVID-19 has dropped to 64 percent, the Israeli government announced late Monday. There was also a smaller drop in the vaccine’s efficacy in preventing hospitalizations and more serious illness. The decline in effectivity was observed amid the spread of the Delta variant of the…
Heart Inflammation Warning to Be Added to mRNA Vaccine Fact Sheet: FDA
The Food and Drug Administration (FDA) said on Wednesday that it will add a warning of heart inflammation to the fact sheet for the Pfizer and Moderna mRNA COVID-19 vaccines that are given to patients prior to vaccination. At a meeting of the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices…
Victoria to Lead Clinical Trials of Australia’s First Locally Made mRNA Vaccine
Australia’s first locally developed mRNA COVID-19 vaccine has been created in Victoria and will begin phase 1 trials within months. Acting Victorian Premier James Merlino announced on Sunday that the state government would invest $5 million into the Monash Institute of Pharmaceutical Sciences (MIPS) to manufacture doses of mRNA vaccine candidates. “This is an incredibly…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`